adenoassoci
viru
aav
use
success
gene
therapi
differ
serotyp
aav
target
specif
organ
tissu
high
effici
exist
increas
demand
manufactur
variou
aav
serotyp
larg
quantiti
preclin
clinic
trial
gener
scalabl
method
describ
studi
effici
produc
aav
serotyp
transfect
fulli
character
cgmp
cell
line
grown
suspens
serumfre
medium
first
product
paramet
evalu
use
model
serotyp
second
nine
aav
serotyp
produc
success
yield
vgl
cell
cultur
subsequ
serotyp
produc
control
bioreactor
product
yield
vgl
similar
yield
obtain
shakeflask
exampl
vgl
cell
cultur
ivpl
measur
h
post
transfect
hpt
period
averag
cell
specif
yield
vg
per
cell
ivp
per
cell
obtain
vg
ivp
ratio
less
success
oper
bioreactor
demonstr
potenti
scaleup
industri
gener
process
manufactur
aav
serotyp
effici
crown
viral
vector
highli
evolv
gene
deliveri
system
therapeut
intervent
last
ten
year
adenoassoci
virus
aav
emerg
one
promis
vector
gene
therapi
vaccin
mueller
flott
extens
review
clinic
trial
phase
phase
ii
clinic
trial
util
aav
carri
worldwid
jump
http
wwwwileycomlegacywileychigenmedclin
access
date
decemb
edelstein
et
al
safeti
efficaci
aav
vector
aav
serotyp
evalu
clinic
trial
treatment
differ
diseas
includ
parkinson
diseas
eberl
et
al
lewitt
et
al
cystic
fibrosi
moss
et
al
wagner
et
al
hemophilia
b
manno
et
al
manno
et
al
rheumatoid
arthriti
meas
et
al
leber
congenit
amaurosi
hauswirth
et
al
maguir
et
al
simonelli
et
al
treatment
lipoprotein
lipas
defici
mingozzi
et
al
stroe
et
al
recent
european
medicin
agenc
recommend
approv
western
world
first
aavmedi
gene
therapi
product
ylaherttuala
anim
studi
aav
shown
potenti
use
vaccin
either
correspond
author
tel
fax
email
address
aminekamen
gmailcom
amin
kamen
cnrcnrcgcca
aa
kamen
attach
antigen
aav
capsid
nieto
et
al
rybnik
et
al
introduc
gene
particular
antigen
sipo
et
al
xin
et
al
induc
humor
respons
logan
alexand
review
potenti
aav
use
tool
manipul
immun
system
respons
mice
challeng
human
papillomaviru
protect
vaccin
adenoassoci
viru
like
particl
aavlp
consist
contain
epitop
insert
posit
respect
nieto
et
al
aavhiv
vector
express
env
tat
rev
gene
show
posit
result
use
balbc
mice
given
hiv
vaccin
xin
et
al
vaccin
sar
coronaviru
sarscov
develop
test
balbc
mice
clone
receptor
bind
domain
aav
vector
du
et
al
differ
variant
natur
occur
synthes
capsid
sequenc
aav
report
howev
commonli
studi
eleven
aav
serotyp
isol
human
simian
rhesu
cynomolgu
monkey
serotyp
rutledg
et
al
xiao
et
al
believ
recombin
product
aav
serotyp
extens
studi
deliv
gene
treat
varieti
diseas
unabl
replic
absenc
helper
virus
date
known
human
pathogen
associ
wildtyp
aav
infect
also
persist
longterm
transgen
express
level
achiev
xiao
et
al
transduc
divid
nondivid
cell
report
humor
respons
infect
common
neutral
antibodi
present
rang
human
popul
throughout
world
depend
age
group
countri
suggest
limit
potenti
deliveri
system
erl
et
al
moskalenko
et
al
boutin
et
al
investig
humor
respons
natur
exposur
aav
type
report
four
igg
subclass
produc
conclud
vector
base
best
candid
gene
therapi
human
mani
research
consid
use
differ
serotyp
aav
circumv
preexist
immun
respons
importantli
observ
serotyp
aav
transduc
cell
differ
organ
variou
effici
therefor
specif
aav
serotyp
could
select
effici
gene
deliveri
target
tissu
van
vliet
et
al
summar
tissu
specif
transduct
effici
asokan
et
al
review
advanc
use
aav
gene
therapi
applic
summar
best
combin
aav
serotyp
organ
eg
liver
cardiac
musculoskelet
central
nervou
system
eg
parkinson
alzheim
batten
epilepsi
lysosom
storag
disord
eye
serotyp
investig
transduc
rat
myocardium
palomequ
et
al
identifi
best
candid
efficaci
compar
deliveri
gene
differ
region
nervou
system
burger
et
al
gene
deliveri
heart
compar
effici
bish
et
al
shown
effici
deliv
gene
cornea
vitro
compar
sharma
et
al
aav
serotyp
among
serotyp
test
show
effect
cell
mediat
immun
respons
muscl
compar
xin
et
al
attempt
made
construct
laboratoryderiv
serotyp
target
singl
tissu
type
minim
aav
dosag
requir
treatment
exampl
asokan
et
al
engin
chang
properti
new
viru
construct
construct
reduc
gene
express
mous
liver
fold
contrast
high
level
express
observ
muscl
cell
contrast
rel
low
level
express
observ
brain
lin
et
al
show
recombin
differ
capsid
increas
respons
gag
advanc
use
aav
vaccin
show
mix
differ
serotyp
properti
aav
could
engin
maxim
express
target
tissu
deliveri
aav
vaccin
select
intranas
subcutan
muscular
rout
differ
effect
immun
respons
xin
et
al
major
advanc
realiz
molecular
engin
structur
analys
process
aav
vector
grieger
et
al
publish
detail
protocol
product
character
aav
vector
use
serumfre
medium
also
advanc
commerci
manufactur
aav
vector
human
use
asid
improv
suppli
aav
vector
clinic
studi
proof
concept
remain
challeng
thu
limit
number
durat
clinic
trial
need
differ
serotyp
target
specif
tissu
ad
complex
product
purif
analyt
procedur
differ
mode
aav
product
aav
produc
success
produc
cell
line
packag
cell
line
chadeuf
et
al
clark
et
al
farson
et
al
gao
et
al
liu
et
al
thorn
et
al
yuan
et
al
cell
could
anchorag
depend
suspens
produc
cell
line
contain
aav
product
compon
eg
vector
genom
aav
rep
cap
helper
viru
eg
adenoviru
type
use
induc
packag
cell
line
use
two
virus
one
induc
aav
repcap
gene
present
packag
cell
line
suppli
gene
interest
encapsid
stabl
cell
line
clark
et
al
liu
et
al
practic
largescal
manufactur
consist
high
yield
success
proof
concept
transient
transfect
technolog
howev
offer
rapid
gener
materi
proof
concept
transient
transfect
compon
requir
aav
product
suppli
plasmid
combin
plasmid
helper
viru
transient
transfect
done
use
adher
cell
cell
plate
salvetti
et
al
zolotukhin
et
al
cell
factori
drittanti
et
al
roller
bottl
liu
et
al
scale
process
desir
short
period
time
gener
preclinicalclin
materi
materi
requir
proof
concept
method
use
adher
cell
may
need
incub
space
timeconsum
laborintens
process
technolog
advanc
support
anchorag
depend
cell
growth
well
provid
layer
cellcub
unit
corn
life
scienc
tewksburi
usa
liquid
volum
ml
support
cell
select
cell
abl
grow
suspens
altern
scale
convent
bioreactor
duroch
et
al
park
et
al
reed
et
al
major
advantag
transient
transfect
serotypespecif
vector
aav
easili
gener
short
period
time
suppli
capsidrepl
plasmid
choic
along
transgen
helper
plasmid
therefor
transfect
chosen
mode
aav
product
rapidli
gener
preclin
materi
anoth
approach
use
insect
cellbaculoviru
system
aav
manufactur
recent
attract
attent
shown
great
potenti
largescal
manufactur
clinic
materi
meghrou
et
al
mena
et
al
urab
et
al
advantag
challeng
differ
method
extens
review
elsewher
aucoin
et
al
scaleup
product
clinic
grade
biolog
materi
import
cell
line
maintain
high
yield
product
cell
line
use
product
must
gener
suffici
quantiti
master
cell
bank
mcb
full
character
nrcmontreal
facil
gener
maintain
cell
line
human
embryon
kidney
hek
cell
line
meet
requir
mcb
manufactur
gmp
guidelin
work
demonstr
cell
line
capabl
produc
suffici
quantiti
differ
aav
serotyp
plasmidmammalian
cell
system
describ
present
studi
base
transfect
three
plasmid
employ
polyethylenimin
pei
dna
transport
serumfre
medium
system
use
product
differ
serotyp
aav
among
plasmid
suppli
produc
differ
serotyp
aav
adv
helper
transgen
plasmid
remain
product
plasmid
contain
capsid
protein
suppli
product
aav
dictat
serotyp
produc
assum
product
differ
serotyp
may
less
depend
type
capsid
plasmid
use
select
one
serotyp
model
minim
number
experi
necessari
evalu
paramet
optim
therefor
gener
product
protocol
would
suitabl
produc
serotyp
avail
avail
serotyp
select
model
aav
investig
product
paramet
effect
plasmid
dna
concentr
differ
cell
densiti
transfect
effici
product
aav
investig
use
optim
transfect
condit
nine
serotyp
aav
produc
shake
flask
demonstr
product
multipl
serotyp
cgmp
cell
line
scalabl
evalu
produc
two
serotyp
three
run
bioreactor
tripl
plasmid
use
weight
ratio
contain
repcap
plasmid
adenoassoci
viru
type
compris
gene
sequenc
replic
structur
protein
transgen
plasmid
itrcmvegfp
singl
strand
harbor
transgen
enhanc
green
fluoresc
protein
egfp
driven
cytomegaloviru
promot
cmv
aav
invert
termin
repeat
itr
adenoviru
helperfunct
suppli
plasmid
contain
gene
protein
va
rna
aav
pseudotyp
pseudopackag
raavcontain
capsid
respect
itr
transgen
plasmid
serotypespecif
plasmid
provid
jude
samulski
samulski
laboratori
gene
therapi
center
univers
north
carolina
chapel
hill
http
genetherapi
unceduserviceshtm
except
plasmid
serotyp
obtain
penn
vector
core
univers
pennsylvania
philadelphia
pa
http
wwwmed
upennedugtpvectorcoreservicesratesshtml
transfect
done
use
linear
polyethylenimin
pei
polysci
inc
warrington
pa
usa
dna
transport
cgmp
cell
line
nation
research
council
canada
montreal
qc
canada
wwwnrccnrcgccaeng
rdhhtindexhtml
use
aav
product
grown
maintain
suspens
cultur
serumfre
hyclon
thermo
scientif
hyq
medium
supplement
gl
pluron
mm
lglutamin
gl
nahco
hela
cell
maintain
dmem
contain
fb
cell
line
propag
c
co
cell
grown
ml
serumfre
hyq
medium
transfect
ml
transfect
mixtur
shake
flask
h
product
vv
lyse
buffer
concentr
mm
mgcl
triton
mm
tri
buffer
solut
ph
vv
freshli
dilut
benzonas
merck
kgaa
darmstadt
germani
suppli
final
concentr
unit
benzonaseml
digest
hostcel
dna
unpackag
viru
dna
ad
harvest
cell
cultur
h
incub
c
agit
concentr
mgso
ad
obtain
final
concentr
mm
solut
incub
min
addit
mgso
necessari
avoid
aav
aggreg
aav
bind
cellular
compon
releas
lysi
studi
effect
differ
media
aav
yield
cell
mainten
medium
reach
cell
densiti
cell
per
ml
ml
cell
cultur
centrifug
g
min
resuspend
either
invitrogen
burlington
ontario
canada
thermo
scientif
hyclon
logan
ut
usa
fresh
medium
earlier
experi
indic
data
shown
media
good
cell
growth
aav
yield
less
medium
therefor
decid
see
cell
cultur
maintain
medium
replac
medium
time
infect
would
benefici
aav
product
harvest
sampl
purifi
iodixanol
gradient
assay
genom
infect
viral
particl
verifi
effect
cell
densiti
amount
dna
suppli
cell
differ
cell
densiti
transfect
either
gml
gmillion
cell
basi
cell
grown
cellsml
appropri
volum
centrifug
cell
resuspend
fresh
medium
obtain
million
cellsml
cell
densiti
transfect
ml
cell
cultur
volum
pei
dna
ratio
sampl
taken
everi
h
post
transfect
hpt
evalu
potenti
posit
effect
histon
deacetylas
sodium
butyr
butyr
acid
neutral
sodium
hydroxid
neutral
ph
refer
butyr
acid
ad
cell
cultur
cell
densiti
million
cellsml
final
concentr
addit
control
mm
stock
solut
hpt
portion
cell
cultur
monitor
fac
percent
transfect
cell
rel
amount
gfp
signal
gfp
posit
cell
portion
cell
cultur
lyse
determin
concentr
infecti
viral
particl
ivpml
chemap
bioreactor
mannedorf
switzerland
equip
two
pitch
blade
impel
three
vertic
surfac
baffl
use
investig
scalabl
process
product
follow
two
serotyp
list
serotyp
select
subsequ
studi
requir
larger
scale
final
work
volum
adjust
l
agit
set
rpm
temperatur
maintain
c
ph
monitor
control
co
supplement
experi
dissolv
oxygen
maintain
supplement
inlet
ga
oxygen
use
computercontrol
massflow
control
fixmmi
softwar
intellut
norwood
bioreactor
inocul
cell
densiti
approxim
cellsml
viabil
greater
cell
densiti
reach
approxim
cellsml
cell
transfect
peidna
complex
polyplex
pei
dna
ratio
time
harvest
aav
cell
cultur
bioreactor
releas
use
triton
method
solut
ad
directli
bioreactor
lysat
centrifug
g
min
supernat
store
c
process
aav
sampl
ml
purifi
overlay
top
seri
step
gradient
use
iodixanol
concentr
adapt
zolotukhin
et
al
contain
ml
respect
iodixanol
concentr
also
contain
nacl
avoid
aggreg
aav
cellular
protein
neg
charg
nuclear
compon
complet
centrifug
ml
withdrawn
mm
interfac
mark
start
ultracentrifug
g
h
min
sorval
rotor
sorval
ultracentrifug
aav
infect
determin
gene
transfer
assay
gta
use
gfp
report
gene
case
procedur
describ
cheng
et
al
adapt
aav
infect
assay
sampl
dilut
addit
cell
gfp
posit
cell
rang
assur
singl
viru
enter
cell
gfp
express
lyse
sampl
either
assay
without
purif
iodixanol
step
gradient
ultracentrifug
protocol
infect
assay
independ
contamin
dna
reveal
percent
recoveri
iodixanol
purif
step
gfpposit
cell
quantifi
fac
use
cell
suspens
describ
chahal
et
al
hela
cell
anchorag
depend
cell
similar
protocol
briefli
hela
cell
coinfect
wildtyp
adenoviru
similar
cell
h
infect
cell
wash
pb
trypsin
min
c
cell
suspend
medium
contain
serum
inactiv
trypsin
cell
centrifug
resuspend
formaldehyd
solut
pb
gfpposit
cell
quantifi
fac
aav
genom
particl
determin
realtimeqpcr
lyse
sampl
treat
benzonas
purifi
iodixanol
stepgradi
protocol
purifi
sampl
dilut
retreat
unit
benzonas
ml
ensur
remov
hostcel
dna
unpackag
viru
dna
high
pure
viral
nucleic
acid
kit
roch
appliedsci
indianapoli
usa
use
purifi
viral
nucleic
acid
aav
sampl
realtim
polymeras
chain
reaction
rtpcr
sampl
dilut
water
supplement
poli
proteinas
k
solut
standard
curv
gener
rtpcr
run
reaction
perform
lightcycl
instrument
roch
diagnost
canada
reaction
perform
total
volum
l
contain
l
pcr
mix
l
h
l
forward
primer
mm
l
revers
primer
mm
l
master
mix
lightcycl
faststart
sybr
green
roch
diagnost
canada
l
templat
serial
dilut
standard
molecul
unknown
water
neg
control
pcr
condit
follow
preincub
c
min
denatur
c
anneal
cycl
c
extens
c
cmv
forward
primer
cmv
revers
primer
use
data
analysi
perform
use
lightcycl
softwar
roch
diagnost
canada
medium
rank
higher
respect
tabl
aav
yield
term
infect
viral
particl
viral
genom
particl
higher
medium
medium
compar
volumetr
cell
specif
basi
consid
percent
error
associ
infect
viral
particl
assay
vgivp
ratio
may
consid
similar
case
medium
select
medium
choic
aav
product
volumetr
cell
specif
infect
viral
particl
produc
twice
much
obtain
medium
cell
transfect
gml
volumetr
basi
except
cellsml
cell
cultur
higher
initi
cell
densiti
higher
transduc
cell
reflect
gfp
posit
cell
wherea
ivp
yield
consist
approxim
ivpml
cell
cultur
fig
transfect
gfp
posit
cell
increas
proport
increas
initi
cell
densiti
dna
plasmid
suppli
basi
g
cell
percent
cell
transfect
improv
rel
cellsml
cell
cultur
fig
howev
proport
increas
plasmid
dna
higher
cell
densiti
bring
similar
proport
increas
gfp
posit
cell
obtain
cellsml
cell
cultur
set
genom
particl
purifi
iodixanol
protocol
infect
viral
particl
lysat
consist
approxim
vgml
cell
cultur
ivpml
cell
cultur
respect
cell
densiti
even
though
cell
densiti
hpt
higher
higher
initi
cell
densiti
fig
reflect
effici
product
aav
total
cell
hpt
cell
specif
yield
highest
cellsml
cell
cultur
decreas
higher
initi
cell
densiti
vgcell
cell
variou
cell
densiti
million
cellsml
transfect
g
plasmid
dnamillion
cell
fresh
medium
cell
densiti
transfect
ml
cell
cultur
volum
pei
dna
ratio
cell
cultur
harvest
h
post
transfect
hpt
compar
data
fig
replot
reflect
percent
gfp
posit
cell
normal
gfp
posit
cell
obtain
transfect
cell
densiti
cellsml
ivpcel
obtain
cell
densiti
cellsml
fig
increas
number
transfect
cell
addit
sodium
butyr
butyr
acid
observ
concentr
test
percentag
transfect
cell
measur
fac
least
count
remain
approxim
fig
howev
transfect
cell
show
higher
amount
gfp
express
higher
concentr
sodium
butyr
butyr
acid
fig
improv
yield
aav
product
addit
sodium
butyr
butyr
acid
observ
infecti
vector
yield
aav
product
experi
contain
butyr
acid
sodium
butyr
found
lower
compar
correspond
control
fig
fig
cell
densiti
viru
yield
term
genom
infect
viral
particl
concentr
function
cell
densiti
transfect
product
harvest
condit
fig
genom
particl
infect
viral
particl
report
vg
ivp
per
ml
cell
cultur
respect
product
kinet
shown
fig
volumetr
product
genom
infect
viral
particl
increas
function
time
averag
iodixanol
purif
protocol
result
recoveri
infect
viral
particl
cell
lysat
sinc
possibl
estim
genom
particl
concentr
cell
lysat
without
purif
expect
similar
recoveri
viral
genom
particlesml
iodixanol
purifi
aav
sampl
obtain
infect
viral
particl
recoveri
iodixanol
purif
method
howev
result
fig
present
purifi
aav
sampl
without
correct
recoveri
backtrack
volum
cell
cultur
use
exampl
ml
iodixanol
purifi
aav
came
ml
cell
cultur
lysat
therefor
factor
use
calcul
nucleas
resist
genom
particl
aav
produc
cell
cultur
demonstr
product
method
gener
applic
serotyp
methodolog
appli
product
aav
serotyp
use
cell
transfect
ml
serumfre
medium
shake
flask
duplic
infect
viral
particl
assay
use
hela
cell
fig
show
aav
yield
vari
depend
serotyp
independ
type
cell
hela
use
infect
assay
similar
experi
repeat
time
genom
infect
viral
particl
assay
iodixanol
purifi
cell
lysat
cultur
supernat
see
cell
associ
intracellular
releas
extracellular
aav
fig
show
genom
particl
produc
hpt
order
magnitud
vgml
cell
cultur
aav
serotyp
wherea
present
supernat
tabl
show
percent
aav
supernat
differ
aav
serotyp
product
cultur
hpt
aav
serotyp
produc
cell
associ
hpt
show
higher
proport
vg
supernat
respect
aav
serotyp
produc
differ
level
infecti
viral
particl
note
aav
infect
assay
done
use
either
hela
cell
fig
aav
serotyp
tissu
specif
fig
aav
serotyp
produc
use
cell
cell
densiti
cellsml
ml
serumfre
medium
shake
flask
duplic
cell
cultur
harvest
h
post
transfect
hpt
infect
viral
particl
assay
use
hela
cell
fig
aav
serotyp
produc
use
cell
cell
densiti
cellsml
ml
serumfre
medium
shake
flask
duplic
cell
cultur
harvest
h
post
transfect
hpt
whole
cell
cultur
supernat
cell
cultur
remov
cell
pellet
centrifug
purifi
iodixanol
protocol
assay
genom
pcr
infect
viral
particl
use
cell
concentr
therefor
infect
assay
reflect
similar
inform
compar
purpos
use
indic
vector
function
activ
infect
cell
capabl
express
gene
genom
particl
obtain
realtim
qpcr
back
calcul
concentr
cell
cultur
dive
factor
load
tube
ml
withdrawn
percent
genom
particl
present
supernat
calcul
divid
vg
supernatantml
cell
cultur
vg
whole
cell
cultureml
shown
fig
multipli
fig
bioreactor
inocul
cell
densiti
cellsml
viabil
cell
transfect
peidna
complex
polyplex
pei
dna
ratio
serumfre
medium
produc
total
cell
cultur
volum
start
transfect
ml
sampl
taken
everi
h
interv
hpt
figur
show
genom
particl
yield
vgml
whole
cell
cultur
vgml
supernat
cell
cultur
vgivp
ratio
cell
specif
yield
term
vgtotal
cell
ivptot
cell
b
total
cell
countsml
cultur
percent
gfp
posit
cell
c
demonstr
scalabl
potenti
industri
process
transfect
perform
control
bioreactor
product
kinet
similar
serotyp
therefor
detail
kinet
report
product
fig
correspond
run
tabl
sampl
taken
interv
cell
continu
grow
densiti
cellsml
viabil
hpt
vg
ivp
detect
supernat
similar
shake
flask
experi
tabl
fig
cell
specif
product
term
vgtotal
cell
ivptot
cell
fig
also
order
magnitud
obtain
shake
flask
experi
fig
transfect
show
cell
express
gfp
hpt
even
though
viabil
start
decreas
total
cell
count
still
increas
therefor
percent
gfp
posit
cell
start
show
declin
fig
tabl
yield
obtain
bioreactor
vgml
rsd
ivpml
rsd
vgivp
run
std
dev
run
std
dev
run
std
dev
rsd
rel
standard
deviat
assay
sampl
whole
cell
cultur
broth
treat
bioreactor
maxim
recoveri
aav
produc
streamlin
overal
process
elimin
step
harvest
centrifug
microfiltr
resuspens
cell
pellet
disrupt
cell
viru
extract
concentr
triton
lower
affect
activ
benzonas
use
reduc
nonvir
dna
nonencapsid
aav
dna
present
lysat
benzonas
addit
also
result
reduct
medium
viscos
triton
cell
cultur
gave
similar
infecti
aav
yield
compar
yield
freezethaw
method
data
shown
maximum
vg
ivp
produc
l
cell
cultur
produc
l
bioreactor
less
hpt
yield
two
run
one
run
obtain
bioreactor
experi
summar
tabl
fig
demonstr
certain
improv
overal
gfp
posit
cell
higher
cell
densiti
plasmid
dna
suppli
basi
gmillion
cell
improv
worth
cost
addit
extra
plasmid
cell
cultur
higher
dna
concentr
show
significantli
larger
number
aggreg
result
probabl
due
excess
plasmid
dna
high
concentr
pei
associ
dna
polyplex
form
higher
dna
load
time
transfect
polyplex
net
posit
charg
hypothes
polyplex
present
excess
may
act
bridg
cell
usual
neg
charg
caus
aggreg
therefor
pei
dna
ratio
use
transfect
done
studi
base
earlier
work
author
laboratori
observ
recommend
depend
formul
serumfre
medium
select
proprietari
natur
commerci
serumfre
medium
use
difficult
specul
effect
macromolecul
present
cell
cultur
medium
also
difficult
assess
interact
polyplex
mechan
transfect
park
et
al
show
quantiti
dna
optim
aav
product
depend
cell
line
mode
product
anchorag
suspens
type
medium
optim
dna
concentr
suspens
cell
gml
adapt
suspens
yield
vgcell
respect
anchorag
depend
cell
optim
dna
concentr
gml
yield
vgcell
park
et
al
note
method
determin
genom
particl
standard
vari
one
laboratori
anoth
aucoin
et
al
among
differ
media
test
hilding
et
al
report
optim
aav
yield
obtain
g
dnaml
pei
dna
ratio
medium
compos
mixtur
rpmi
excel
media
also
report
cut
dna
half
reduc
yield
increas
dna
proport
gain
yield
cellspecif
yield
low
cell
densiti
report
vgcell
chadeuf
et
al
collaco
et
al
drittanti
et
al
feng
et
al
okada
et
al
gfp
lacz
report
gene
product
cell
use
plasmid
transfect
technolog
volumetr
product
increas
proport
cell
densiti
higher
cellsml
fig
also
reflect
cellspecif
yield
fig
similar
reduc
transfect
effici
observ
hilding
et
al
conclud
could
dnapei
polyplex
ad
volumetr
basi
low
yield
cell
cultur
higher
cell
densiti
could
due
exhaust
key
compon
medium
necessari
aav
product
cell
mainten
observ
also
indic
potenti
improv
aav
product
yield
optim
medium
design
feed
strategi
high
cell
densiti
cultur
fedbatch
mode
problem
remain
larg
unsolv
requir
detail
analys
better
understand
cell
metabol
kinet
mechan
involv
transfect
express
process
cell
densiti
effect
metabol
limit
observ
author
laboratori
express
system
henri
et
al
address
phenomenon
propos
perfus
system
adenoviru
product
allevi
nutrient
limit
caus
high
cell
densiti
cultur
studi
decid
keep
produc
aav
transfect
cell
cell
densiti
cellsml
mean
medium
replac
fedbatch
techniqu
develop
addit
found
improv
transfect
effici
aav
yield
sodium
butyr
butyr
acid
regul
gene
express
keep
histon
acetyl
state
inhibit
histon
deacetylas
easi
access
regulatori
factor
dna
vidali
et
al
exploit
improv
product
yield
aav
case
use
sodium
butyr
increas
backliw
et
al
hunt
et
al
jiang
sharfstein
senaestev
et
al
yield
protein
virus
case
effect
senaestev
et
al
present
studi
although
express
level
transgen
transfect
cell
directli
proport
concentr
sodium
butyr
butyr
acid
use
contribut
increas
yield
aav
product
base
high
express
gfp
protein
addit
sodium
butyr
butyr
acid
would
also
produc
rep
protein
excess
rep
protein
toxic
effect
cell
chang
shenk
chang
et
al
clark
et
al
li
et
al
yang
et
al
zhou
tremp
therefor
low
aav
yield
presenc
sodium
butyr
butyr
acid
could
due
accumul
toxic
protein
cell
cultur
environ
lentiviru
product
cell
increas
use
sodium
butyr
ansorg
et
al
karolewski
et
al
caffein
elli
et
al
product
increas
sodium
butyr
present
studi
caffein
elli
et
al
use
cell
howev
increas
aav
product
shown
addit
mm
sodium
butyr
insect
cellsbaculoviru
system
use
baculovirusmedi
transduct
hek
cell
gave
higher
aav
yield
addit
sodium
butyr
kinet
aav
product
show
infecti
titer
lag
behind
genom
particl
titer
like
matur
infecti
particl
took
place
format
capsid
encapsid
viral
genom
fig
viral
genom
vg
particl
start
accumul
earli
hpt
howev
ivp
seen
hpt
could
due
h
sampl
interv
sensit
assay
genom
viral
particl
produc
earlier
infect
viral
particl
matur
later
myer
carter
show
radioact
puls
chase
label
method
aav
capsid
protein
assembl
empti
capsid
quickli
experi
suggest
empti
capsid
later
transfer
dnacontain
full
particl
defectiveinterf
particl
show
matur
stabl
full
particl
took
much
longer
term
sever
hour
wherea
empti
capsid
appear
rapidli
gfp
posit
cell
remain
hpt
suggest
secondari
infect
seen
fig
xiao
argu
mutant
bind
strongli
hspg
would
show
less
particl
free
medium
readsorpt
onto
cell
membran
reentri
live
cell
result
low
aav
yield
uncoat
degrad
reenter
virus
argument
impli
least
small
increas
number
transduc
cell
later
stage
aav
product
equal
probabl
adsorpt
nontransfect
cell
increas
gfp
posit
cell
observ
fig
low
vgivp
ratio
less
hpt
cell
cultur
indic
accept
encapsid
vector
achiev
transfect
technolog
use
cell
studi
shown
differ
serotyp
aav
produc
use
pei
transfect
technolog
serumfre
medium
yield
close
vgl
cell
cultur
fig
use
cellsml
g
total
dnaml
cell
cultur
determin
first
purifi
iodixanol
protocol
remov
plasmid
nonencapsul
viral
dna
present
sampl
infecti
viral
particl
assay
use
cell
aav
serotyp
differ
specif
cell
line
infecti
viral
particl
product
reflect
infect
assay
provid
demonstr
differ
aav
serotyp
produc
use
scalabl
process
function
term
infect
result
indic
hela
cell
line
use
transduct
infect
assay
variabl
permiss
differ
aav
serotyp
titer
publish
care
evalu
highli
depend
type
assay
use
determin
total
function
titer
cellbas
assay
use
titer
serotyp
compar
determin
function
loss
vector
process
genom
particl
pcr
base
assay
may
use
titer
differ
serotyp
compar
grieger
et
al
quantit
aav
review
aucoin
et
al
strongli
suggest
comparison
data
publish
literatur
done
great
care
consid
differ
express
system
differ
quantit
method
use
bioreactor
experi
product
two
run
one
run
demonstr
scalabl
process
tabl
although
total
cell
continu
increas
hpt
cell
viabil
start
decreas
bioreactor
experi
provid
similar
yield
observ
shake
flask
experi
similar
condit
demonstr
scalabl
process
time
harvest
may
set
preferenti
hpt
fig
volumetr
product
infecti
genom
viral
particl
remain
constant
around
ivpl
vgl
respect
hpt
cell
specif
yield
vgcell
ivpcel
obtain
use
differ
plasmid
construct
medium
select
provid
better
condit
improv
earlier
yield
duroch
et
al
report
better
encapsid
vgivp
ratio
higher
cell
densiti
cellsml
without
medium
exchang
cell
adapt
loos
suspens
bioreactor
cell
densiti
cellsml
fb
gave
cellspecif
yield
ivpcel
genom
particl
per
cell
report
park
et
al
gener
produc
higher
cellspecif
infecti
particl
cell
cell
vs
cell
park
et
al
yuan
et
al
produc
singl
strand
ssaav
selfcompl
scaav
aav
vector
serotyp
aav
produc
cell
line
tripl
transfect
group
report
vector
genom
particl
per
nunc
cell
factori
genom
particl
per
cell
cell
line
produc
vector
vgtransduc
unit
tu
ratio
vgtu
ratio
tripl
transfect
method
lock
et
al
produc
transient
transfect
small
scale
use
anchorag
depend
cell
yield
rang
genom
copiescel
ten
liter
product
gave
yield
rang
genom
copi
anchorag
depend
cell
although
cell
product
grown
serum
free
medium
kept
fetal
bovin
serum
prior
transfect
grieger
samulski
report
high
aav
yield
use
cell
line
select
high
transfect
effici
high
aav
product
cell
line
abl
produc
vgcell
serumfre
suspens
cell
cultur
show
great
potenti
yet
explor
optim
cell
line
better
optim
transfect
effici
author
laboratori
baculovirusinsect
cell
system
well
optim
process
support
high
cell
densiti
product
aav
vector
combin
low
moi
fedbatch
product
strategi
shown
insect
cellsbaculoviru
system
aav
yield
increas
sevenfold
approxim
vgl
ivpml
cell
cultur
obtain
bioreactor
experi
harvest
cell
densiti
cellsml
mena
et
al
proport
similar
cell
specif
product
transfect
low
cell
densiti
report
manuscript
process
standpoint
remark
despit
limit
process
improv
oper
low
cell
densiti
larg
scale
transient
transfect
technolog
perform
well
baculovirusinsect
cell
technolog
product
aav
serotyp
underlin
yet
nonexploit
potenti
transient
transfect
cell
suspens
cultur
high
yield
larg
scale
industri
product
aav
serotyp
evalu
studi
support
recent
work
grieger
samulski
also
base
data
studi
said
confid
serotyp
easili
produc
larger
scale
cgmp
cell
line
use
present
gener
protocol
demonstr
human
embryon
kidney
hek
cell
line
fulli
character
gmp
master
cell
bank
capabl
produc
differ
serotyp
aav
aav
suspens
cultur
transient
transfect
serumfre
medium
without
medium
exchang
three
bioreactor
run
show
yield
compar
shakeflask
run
correspond
serotyp
therefor
show
potenti
scaleup
industri
gener
process
manufactur
effici
aav
serotyp
